Calithera Biosciences | DEFM14A: Definitive proxy statement relating to merger or acquisition
Calithera Biosciences | DEFA14A: Others
Calithera Biosciences | 15-12G: Notice of termination of registration of a class of securities under Section 12(g) (and amendment thereto)
Calithera Biosciences | S-8 POS: S-8 POS
Calithera Biosciences | S-8 POS: S-8 POS
Calithera Biosciences | S-8 POS: S-8 POS
Calithera Biosciences | S-8 POS: S-8 POS
Calithera Biosciences | S-8 POS: S-8 POS
Calithera Biosciences | S-8 POS: S-8 POS
Calithera Biosciences | S-8 POS: S-8 POS
Calithera Biosciences | S-8 POS: S-8 POS
Calithera Biosciences | S-8 POS: S-8 POS
Calithera Biosciences | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Calithera Biosciences | DEFA14A: Others
Calithera Biosciences | 8-K: Current report
Calithera Biosciences | DEFA14A: Others
Calithera Biosciences | 8-K: Current report
Calithera Biosciences | 8-K: Calithera Biosciences Reports Third Quarter 2022 Financial Results and Business Update
Calithera Biosciences | 8-K: Current report
Calithera Biosciences | NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB
No Data